HRP20161583T1 - Postupak slabljenja alergija uzrokovanih alergenima iz okoliša - Google Patents
Postupak slabljenja alergija uzrokovanih alergenima iz okoliša Download PDFInfo
- Publication number
- HRP20161583T1 HRP20161583T1 HRP20161583TT HRP20161583T HRP20161583T1 HR P20161583 T1 HRP20161583 T1 HR P20161583T1 HR P20161583T T HRP20161583T T HR P20161583TT HR P20161583 T HRP20161583 T HR P20161583T HR P20161583 T1 HRP20161583 T1 HR P20161583T1
- Authority
- HR
- Croatia
- Prior art keywords
- fel
- allergen
- preparation
- animal
- allergic response
- Prior art date
Links
- 239000013566 allergen Substances 0.000 title claims 24
- 238000000034 method Methods 0.000 title claims 8
- 206010020751 Hypersensitivity Diseases 0.000 title claims 2
- 230000007815 allergy Effects 0.000 title claims 2
- 230000007613 environmental effect Effects 0.000 title 1
- 238000002360 preparation method Methods 0.000 claims 16
- 241001465754 Metazoa Species 0.000 claims 14
- 208000026935 allergic disease Diseases 0.000 claims 13
- 241000282326 Felis catus Species 0.000 claims 6
- 210000003630 histaminocyte Anatomy 0.000 claims 5
- 208000024891 symptom Diseases 0.000 claims 3
- 102000003839 Human Proteins Human genes 0.000 claims 2
- 108090000144 Human Proteins Proteins 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 239000003205 fragrance Substances 0.000 claims 2
- 235000015097 nutrients Nutrition 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 239000000443 aerosol Substances 0.000 claims 1
- 230000000172 allergic effect Effects 0.000 claims 1
- 235000019568 aromas Nutrition 0.000 claims 1
- 208000010668 atopic eczema Diseases 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 239000003599 detergent Substances 0.000 claims 1
- 235000012041 food component Nutrition 0.000 claims 1
- 239000005417 food ingredient Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 230000003313 weakening effect Effects 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Birds (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Claims (16)
1. Postupak radi slabljenja ili sprječavanja alergijskog odgovora kod životinje sklone pojavi alergijskog odgovora na alergen Fel D1 u okolišu, naznačen time što se obuhvaća stavljanje u kontakt izvora alergena Fel D1 u okolišu s pripravkom koji sadrži molekulu koja sadrži protutijelo protiv Fel D1 koje inhibira sposobnost vezanja alergena Fel D1 na IgE prisutan na mastocitima kod navedene životinje sklone pojavi alergijskog odgovora na alergen Fel D1.
2. Postupak u skladu s patentnim zahtjevom 1, naznačen time što je životinja sklona pojavi alergijskog odgovora čovjek, mačka ili pas.
3. Postupak u skladu s patentnim zahtjevom 1, naznačen time što pripravak je u obliku aerosola, tekućine, gela, polučvrste tvari, krutine ili praha.
4. Postupak u skladu s patentnim zahtjevom 3, naznačen time što se pripravak primjenjuje na površinu u okolišu.
5. Postupak u skladu s patentnim zahtjevom 1, naznačen time što do koraka stavljanja u kontakt dolazi kada pripravak konzumira mačka koja se nalazi u navedenom okolišu.
6. Postupak u skladu s patentnim zahtjevom 1, naznačen time što je molekula hibridna molekula koja sadrži u najmanju ruku vežući dio protutijela protiv Fel D1 i najmanje dio ljudskog proteina.
7. Postupak u skladu s patentnim zahtjevom 6, naznačen time što je ljudski protein IgG.
8. Pripravak formuliran kao prehrambeni pripravak za kućne mačke, koji sadrži molekulu koja sadrži protutijelo protiv Fel D1, gdje navedeno protutijelo protiv Fel D1 inhibira sposobnost vezanja alergena Fel D1 na IgE prisutan na mastocitima kod životinje sklone pojavi alergijskog odgovora na alergen Fel D1, naznačen time što je namijenjen upotrebi u obradi mačke kao izvora alergena Fel D1 radi slabljenja ili sprječavanja najmanje jednog simptoma alergijskog odgovora kod životinje na alergen Fel D1 u okolišu.
9. Pripravak u skladu s patentnim zahtjevom 8, naznačen time što molekula sadrži u najmanju ruku dio protutijela protiv Fel D1 specifičnog za alergen Fel D1.
10. Pripravak u skladu s patentnim zahtjevom 8, naznačen time što molekula sadrži u najmanju ruku dio protutijela protiv Fel D1 koje se specifično veže na Fel D1, fuzioniran s u najmanju ruku dijelom molekule IgG.
11. Pripravak u skladu s patentnim zahtjevom 8, naznačen time što je u obliku pogodnom za oralnu primjenu kod mačaka.
12. Pripravak u skladu s patentnim zahtjevom 8, naznačen time što dodatno sadrži jedan ili više od hranjive tvari, nutrijenta, arome, mirisne tvari, stabilizatora, surfaktanta, veziva ili detergenta.
13. Pripravak u skladu s patentnim zahtjevom 8, naznačen time što je alergen Fel D1 koji se rasprostranjuje oralno alergen podrijetlom iz kućnog ljubimca, gdje ta molekula sadrži u najmanju ruku dio protutijela protiv Fel D1 koje se specifično veže na alergen Fel D1.
14. Komplet namijenjen slabljenju ili sprječavanju alergijskog odgovora kod životinje na alergen Fel D1 u okolišu, naznačen time što u odvojenim spremnicima, u istom pakiranju, sadrži, kao što je prikladno za komplet, kao komponentu najmanje jedan pripravak koji sadrži najmanje jednu molekulu koja sadrži protutijelo protiv Fel D1 koje inhibira sposobnost vezanja alergena Fel D1 na IgE prisutan na mastocitima kod životinje sklone pojavi alergijskog odgovora na alergen Fel D1 i najmanje jedno od (1) jednog ili više sastojaka hrane namijenjenih konzumaciji od strane životinje koja je izvor alergena u okolišu, (2) palatansa, arome ili mirisa, (3) jednog ili više vitamina i minerala namijenjenih životinji koja je izvor alergena Fel D1, i (4) jednog ili više lijekova za sprječavanje ili liječenje alergija ili alergijskih simptoma, te upute o upotreba pripravaka i komponenata kompleta za smanjivanje ili sprječavanje alergijskog odgovora kod osjetljive životinje.
15. Komplet u skladu s patentnim zahtjevom 14, naznačen time što se u uputama o upotrebi nalaze upute za davanje pripravka u hrani životinji koja je izvor alergena Fel D1 u količini dovoljnoj za vezanje na alergen Fel D1, tako da se isti ne može vezati na IgE prisutan na mastocitima kod životinje sklone pojavi alergijskog odgovora.
16. Upotreba pripravka koji sadrži najmanje jednu molekulu koja sadrži protutijelo protiv Fel D1, gdje navedeno protutijelo protiv Fel D1 inhibira sposobnost vezanja alergena Fel D1 na IgE prisutan na mastocitima kod životinje sklone pojavi alergijskog odgovora na alergen Fel D1, naznačena time što je pripravak namijenjen pripravi medikamenta za obrada mačke kao izvor alergena Fel D1 u okolišu radi slabljenja ili sprječavanja najmanje jednog simptoma alergijskog odgovora kod navedene životinje sklone pojavi alergijskog odgovora na alergen Fel D1 u okolišu.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95884507P | 2007-07-09 | 2007-07-09 | |
| PCT/US2008/008405 WO2009009061A1 (en) | 2007-07-09 | 2008-07-09 | Methods for reducing allergies caused by environmental allergens |
| EP08780052.0A EP2162133B1 (en) | 2007-07-09 | 2008-07-09 | Methods for reducing allergies caused by environmental allergens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20161583T1 true HRP20161583T1 (hr) | 2016-12-30 |
Family
ID=40228919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20161583TT HRP20161583T1 (hr) | 2007-07-09 | 2016-11-29 | Postupak slabljenja alergija uzrokovanih alergenima iz okoliša |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8454953B2 (hr) |
| EP (2) | EP2162133B1 (hr) |
| JP (3) | JP5873631B2 (hr) |
| CN (2) | CN101686974A (hr) |
| AU (1) | AU2008275624B2 (hr) |
| BR (1) | BRPI0813703A2 (hr) |
| CA (1) | CA2693416C (hr) |
| DK (1) | DK2162133T3 (hr) |
| ES (2) | ES2599639T3 (hr) |
| HR (1) | HRP20161583T1 (hr) |
| HU (2) | HUE034431T2 (hr) |
| LT (1) | LT2162133T (hr) |
| PL (2) | PL2162133T3 (hr) |
| PT (1) | PT2162133T (hr) |
| RU (1) | RU2491937C2 (hr) |
| SI (1) | SI2162133T1 (hr) |
| WO (1) | WO2009009061A1 (hr) |
| ZA (1) | ZA201000920B (hr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9388236B2 (en) * | 2007-07-09 | 2016-07-12 | Nestec Sa | Methods for reducing allergies caused by environmental allergens |
| BR112012008120B1 (pt) * | 2009-07-30 | 2021-03-02 | Société Des Produits Nestlé S.A | composições alimentícias úmidas, seu método de produção, composição alimentícia misturada, e kit |
| RU2553647C2 (ru) * | 2009-08-26 | 2015-06-20 | Нестек С.А. | Пищевые композиции в виде кусочков в желе, имеющие привлекательный внешний вид |
| JO3820B1 (ar) | 2012-05-03 | 2021-01-31 | Regeneron Pharma | أجسام مضادة بشرية لـ fel d1وطرق لاستخدامها |
| EP3036543B1 (en) | 2013-08-23 | 2019-06-19 | Regeneron Pharmaceuticals, Inc. | Diagnostic tests and methods for assessing safety, efficacy or outcome of allergen-specific immunotherapy (sit) |
| US20150175940A1 (en) * | 2013-12-19 | 2015-06-25 | Nestec Sa | Compositions and methods for reducing cat allergens in the environment |
| US20170021010A1 (en) * | 2015-07-21 | 2017-01-26 | David Phillip ERSTEIN | Allergy preventing dosage controlled food packets |
| US11352417B2 (en) | 2016-12-22 | 2022-06-07 | Regeneron Pharmaceuticals, Inc. | Method of treating an allergy with allergen-specific monoclonal antibodies |
| AU2018212707B2 (en) * | 2017-01-24 | 2024-05-09 | Societe Des Produits Nestle S.A. | Compositions comprising anti-Fel D1 antibodies and methods for reducing at least one symptom of human allergy to cats |
| EP3631464A1 (en) * | 2017-05-25 | 2020-04-08 | Société des Produits Nestlé S.A. | Methods for enabling pet ownership |
| CN109100470A (zh) * | 2018-06-29 | 2018-12-28 | 湖北海纳天鹰科技发展有限公司 | 一种空气中过敏原类型的判别方法和装置 |
| WO2022046925A1 (en) | 2020-08-26 | 2022-03-03 | Regeneron Pharmaceuticals, Inc. | Method of treating an allergy with allergen-specific monoclonal antibodies |
| US20220363739A1 (en) * | 2021-05-17 | 2022-11-17 | Société des Produits Nestlé S.A. | Compositions and methods for reducing at least one symptom of human allergy to cats |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX3790E (es) * | 1975-04-04 | 1981-07-20 | Univ California | Metodo para la preparacion de derivados de polipeptido |
| US4748018A (en) | 1984-02-07 | 1988-05-31 | Stolle Research & Development Corp. | Method of passive immunization of mammals using avian antibody |
| CH0225254H1 (en) | 1985-11-25 | 1998-09-15 | Ghen Corp | Specific antibody-containing substance from eggs and method of production and use thereof |
| JPH0753669B2 (ja) * | 1985-11-25 | 1995-06-07 | 株式会社ゲン・コーポレーション | 鶏卵からの特異的抗体含有材料およびその製造方法と用途 |
| AU5958494A (en) * | 1992-12-21 | 1994-07-19 | Tanox Biosystems, Inc. | Allergen-specific iga monoclonal antibodies and related products for allergy treatment |
| DE19523048C1 (de) * | 1995-06-24 | 1996-12-05 | Hoelter Heinz | Filter zur Abscheidung von Allergenen aus Raumluft |
| WO1997033915A1 (de) | 1996-03-12 | 1997-09-18 | Ovoimmun Gmbh | Aviäre, vitelline, gegen hiv-antigene gerichtete antikörper |
| US6504013B1 (en) * | 2000-02-01 | 2003-01-07 | Idexx Laboratories, Inc. | Canine allergy therapeutic recombinant chimeric anti-IgE monoclonal antibody |
| WO2000035484A2 (en) * | 1998-12-18 | 2000-06-22 | Michael Caplan | Methods and compositions for decreasing allergic reactions to surface allergens |
| US6358546B1 (en) * | 1999-01-15 | 2002-03-19 | Ralston Purina Company | Methods for customizing pet food |
| GB0002386D0 (en) | 2000-02-02 | 2000-03-22 | Novartis Nutrition Ag | Therapeutic composition |
| EP1438019A1 (en) * | 2001-10-24 | 2004-07-21 | PARI GmbH Spezialisten für effektive Inhalation | Kit for the preparation of a pharmaceutical composition |
| GB0125594D0 (en) * | 2001-10-25 | 2001-12-19 | Univ Sheffield | Inhibitors for inactivating allergens |
| JP2005074023A (ja) * | 2003-09-01 | 2005-03-24 | Bio Media Co Ltd | アレルゲン不活性化装置 |
| US20050095627A1 (en) * | 2003-09-03 | 2005-05-05 | The Salk Institute For Biological Studies | Multiple antigen detection assays and reagents |
| US20060068947A1 (en) * | 2004-09-28 | 2006-03-30 | Cheri Kempf | Pitching training mat and kit and associated method for training pitchers |
| JP4591070B2 (ja) * | 2004-12-20 | 2010-12-01 | 東洋紡績株式会社 | 蛋白質担持フィルター及びその製造方法 |
| US20060210590A1 (en) * | 2005-02-03 | 2006-09-21 | Alk-Abello A/S | Minor allergen control to increase safety of immunotherapy |
| JP2006261881A (ja) * | 2005-03-16 | 2006-09-28 | Toshiba Corp | 画像形成装置および画像形成方法 |
| WO2006097530A2 (en) * | 2005-03-18 | 2006-09-21 | Cytos Biotechnology Ag | Cat allergen fusion proteins and uses thereof |
| GB0513878D0 (en) * | 2005-07-06 | 2005-08-10 | Mars Inc | Cat allergen |
| WO2007113633A2 (en) | 2006-04-03 | 2007-10-11 | Pfizer Products Inc. | Immunogenic compositions comprising cat allergen fel dl |
-
2008
- 2008-07-09 SI SI200831680A patent/SI2162133T1/sl unknown
- 2008-07-09 CA CA2693416A patent/CA2693416C/en active Active
- 2008-07-09 PL PL08780052T patent/PL2162133T3/pl unknown
- 2008-07-09 EP EP08780052.0A patent/EP2162133B1/en active Active
- 2008-07-09 HU HUE13195640A patent/HUE034431T2/en unknown
- 2008-07-09 RU RU2010104443/15A patent/RU2491937C2/ru active
- 2008-07-09 US US12/452,450 patent/US8454953B2/en active Active
- 2008-07-09 BR BRPI0813703A patent/BRPI0813703A2/pt not_active Application Discontinuation
- 2008-07-09 ES ES08780052.0T patent/ES2599639T3/es active Active
- 2008-07-09 EP EP13195640.1A patent/EP2705846B1/en active Active
- 2008-07-09 AU AU2008275624A patent/AU2008275624B2/en active Active
- 2008-07-09 PL PL13195640T patent/PL2705846T3/pl unknown
- 2008-07-09 ES ES13195640.1T patent/ES2635870T3/es active Active
- 2008-07-09 CN CN200880024002A patent/CN101686974A/zh active Pending
- 2008-07-09 HU HUE08780052A patent/HUE032078T2/en unknown
- 2008-07-09 PT PT87800520T patent/PT2162133T/pt unknown
- 2008-07-09 JP JP2010516043A patent/JP5873631B2/ja active Active
- 2008-07-09 LT LTEP08780052.0T patent/LT2162133T/lt unknown
- 2008-07-09 DK DK08780052.0T patent/DK2162133T3/en active
- 2008-07-09 WO PCT/US2008/008405 patent/WO2009009061A1/en active Application Filing
- 2008-07-09 CN CN201510009448.4A patent/CN104642743A/zh active Pending
-
2010
- 2010-02-08 ZA ZA2010/00920A patent/ZA201000920B/en unknown
-
2014
- 2014-12-25 JP JP2014262655A patent/JP5969585B2/ja active Active
-
2016
- 2016-07-07 JP JP2016135150A patent/JP6219454B2/ja active Active
- 2016-11-29 HR HRP20161583TT patent/HRP20161583T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20161583T1 (hr) | Postupak slabljenja alergija uzrokovanih alergenima iz okoliša | |
| JP2010533179A5 (hr) | ||
| AU2011320994B2 (en) | Methods and compositions suitable for promoting healthy skin | |
| Mubito et al. | Antimicrobial use in the poultry industry in Dar-es-Salaam, Tanzania and public health implications | |
| AU2013305719A1 (en) | Managing weight loss and body mass | |
| JP2013516188A5 (hr) | ||
| CA2854268A1 (en) | Odor control systems with customizable aroma | |
| JP2009517484A (ja) | 尿路結石症を予防又は治療するための組成物及び方法 | |
| CA2890091A1 (en) | Flavored drinking waters and methods for improving hydration for animals | |
| Wood et al. | Ethanol-induced conditioned partner preference in female mice | |
| Thabet et al. | Molecular and biochemical studies on bovine ephemeral fever | |
| JP3145622U (ja) | ペット用消臭おやつ | |
| RU2006112789A (ru) | Биоактивный ветеринарный препарат и способ его применения | |
| Symes | Idiopathic epilepsy-the dietary solution and the role of the GARD | |
| Foy et al. | Stability of thiamine in extemporaneously compounded suspensions | |
| TH98892A (th) | การรักษาของสุกรด้วยแอนติเจน pcv2 | |
| Fusari et al. | Troponin I evaluation in an atypical outbreak of mulberry heart desease | |
| Warkentin | Follow-up of three large community-based programs to reduce anaemia among children 24-59 months in Ghana, Malawi and Tanzania | |
| BRPI0700747A (pt) | complemento alimentar em formatos variados de biscoitos/bolachas ou rações | |
| BR102012015522A8 (pt) | composição de sais acidificantes reguladores do equilibrio ácido básico da urina em gatos, sua utilização e produto assim obtido | |
| TH131672A (th) | วิธีสำหรับการเตรียมองค์ประกอบทางเภสัชกรรมที่มีเจตนาสำหรับการให้ยาทางปากซึ่งประกอบรวมด้วยออกฤทธิ์ชนิดหนึ่งหรือมากกว่าและองค์ประกอบซึ่งประกอบรวมด้วยสิ่งดังกล่าว |